Format

Send to

Choose Destination
Am J Phys Med Rehabil. 2008 Nov;87(11):890-902. doi: 10.1097/PHM.0b013e31818377b6.

Regenerative injection of elite athletes with career-altering chronic groin pain who fail conservative treatment: a consecutive case series.

Author information

1
Physical Medicine and Rehabilitation Service, Jaime Slullitel Rosario Orthopedic and Trauma Institute, Argentina.

Abstract

OBJECTIVE:

To obtain multisport and long-term outcome data from the use of regenerative injection therapy on career-threatened athletes.

DESIGN:

Consecutive enrollment of elite performance-limited athletes with chronic groin/abdominal pain who failed a conservative treatment trial. The treatment consisted of monthly injections of 12.5% dextrose in 0.5% lidocaine in abdominal and adductor attachments on the pubis. Injection of the nociceptive source was confirmed by repetition of resistive testing 5 mins after injection.

RESULTS:

Seventy-five athletes were enrolled. Seventy-two athletes (39 rugby, 29 soccer, and 4 other) completed the minimum two-treatment protocol. Their data revealed a mean groin pain history of 11 (3-60) mos. Average number of treatments received was 3 (1-6). Individual paired t tests for Visual Analog Scale (VAS) of pain with sport (VAS Pain) and Nirschl pain phase scale measured at 0 and an average of 26 (6-73) mos indicated VAS Pain improvement of 82% (P < 10) and Nirschl pain phase scale improvement of 78% (P < 10). Six athletes did not improve following regenerative injection therapy treatment, and the remaining 66 returned to unrestricted sport. Return to unrestricted sport occurred in an average of 3 (1-5) mos.

CONCLUSIONS:

Athletes returned to full elite-level performance in a timely and sustainable manner after regenerative injection therapy using dextrose.

PMID:
18688199
DOI:
10.1097/PHM.0b013e31818377b6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center